Sources of bias in observational studies of covid-19 vaccine effectiveness

Kaiser Fung; Mark Jones; Peter Doshi

doi:10.1111/jep.13839

Sources of bias in observational studies of covid-19 vaccine effectiveness

Kaiser Fung, Mark Jones, Peter Doshi^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Comment/debate/opinion › Research › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	Journal of Evaluation in Clinical Practice
DOIs	https://doi.org/10.1111/jep.13839
Publication status	Published - 26 Mar 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jep.13839Licence: CC BY

Cite this

@article{239971d924a641d8b76b7a5cef3e2494,

title = "Sources of bias in observational studies of covid-19 vaccine effectiveness",

author = "Kaiser Fung and Mark Jones and Peter Doshi",

note = "Funding Information: We have the following interests to declare: Peter Doshi has received travel funds from the European Respiratory Society (2012) and Uppsala Monitoring Center (2018); grants from the FDA (through University of Maryland M‐CERSI; 2020), Laura and John Arnold Foundation (2017‐22), American Association of Colleges of Pharmacy (2015), Patient‐Centered Outcomes Research Institute (2014‐16), Cochrane Methods Innovations Fund (2016‐18), and UK National Institute for Health Research (2011‐14); was an unpaid IMEDS steering committee member at the Reagan‐Udall Foundation for the FDA (2016‐2020), and is an editor at The BMJ. KF, MJ: None. ",

year = "2023",

month = mar,

day = "26",

doi = "10.1111/jep.13839",

language = "English",

pages = "1--7",

journal = "Journal of Evaluation in Clinical Practice",

issn = "1356-1294",

publisher = "Blackwell Publishing",

}

TY - JOUR

T1 - Sources of bias in observational studies of covid-19 vaccine effectiveness

AU - Fung, Kaiser

AU - Jones, Mark

AU - Doshi, Peter

N1 - Funding Information: We have the following interests to declare: Peter Doshi has received travel funds from the European Respiratory Society (2012) and Uppsala Monitoring Center (2018); grants from the FDA (through University of Maryland M‐CERSI; 2020), Laura and John Arnold Foundation (2017‐22), American Association of Colleges of Pharmacy (2015), Patient‐Centered Outcomes Research Institute (2014‐16), Cochrane Methods Innovations Fund (2016‐18), and UK National Institute for Health Research (2011‐14); was an unpaid IMEDS steering committee member at the Reagan‐Udall Foundation for the FDA (2016‐2020), and is an editor at The BMJ. KF, MJ: None.

PY - 2023/3/26

Y1 - 2023/3/26

UR - http://www.scopus.com/inward/record.url?scp=85150996245&partnerID=8YFLogxK

U2 - 10.1111/jep.13839

DO - 10.1111/jep.13839

M3 - Comment/debate/opinion

C2 - 36967517

AN - SCOPUS:85150996245

SN - 1356-1294

SP - 1

EP - 7

JO - Journal of Evaluation in Clinical Practice

JF - Journal of Evaluation in Clinical Practice

ER -

Sources of bias in observational studies of covid-19 vaccine effectiveness

UN SDGs

Access to Document

Other files and links

Cite this